Markets up over COVID-19 vaccines, and US fiscal stimulus enthusiasm - Tuesday Review, February 16

Markets up over COVID-19 vaccines, and US fiscal stimulus enthusiasm - Tuesday Review, February 16

Global markets were close to record gains for the twelfth consecutive session

The US

Investors’ optimism continues to increase, as the number of COVID-19 infections decreases, and the possible $1.9 trillion stimulus package is still under review in the Senate. USA30 rose 0.20%, while USA500 lost 0.08%. TECH100 slipped 0.34%.

Crude oil added 0.9%, reaching $60.05 per barrel.

Gold settled down 1.3% at $1,799 per ounce.

Asia and Australia

Stocks were up, driven by the optimism over the rollout of the COVID-19 vaccine.

Japan225 rose 1.48%.

HongKong45 jumped 1.55%.

Down under, Australia200 added 0.28% after the February minutes from the Reserve Bank showed that a possible lifting of inflation would lead to a significant and sustained tightening in the labor market.

Europe

Markets pushed higher as strong earnings result reinforced the hopes of broad global economic recovery. Germany30 and France40 rose 0.1%. UK100 climbed 0.4%.

Brent oil closed 0.1% higher at $63.35 a barrel.

EUR/USD traded at 1.2146 after it gained 0.2%.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.